Global HLA Typing Transplant Market Size Study & Forecast, by Products and Services (Reagents and Consumables, Instruments, Software and Services) by Technology (Molecular and Non-Molecular Assay Technologies) and Transplant Type (Solid Organ, Hematopoiet

The Global HLA Typing Transplant Market is valued at approximately USD 0.99 billion in 2024 and is anticipated to expand at a compound annual growth rate (CAGR) of 8.40% during the forecast period 2025-2035. HLA typing refers to the process of identifying human leukocyte antigen (HLA) variants to ensure compatibility between donors and recipients in organ and stem cell transplants. Accurate HLA matching is critical for minimizing graft rejection, enhancing transplant success rates, and improving patient outcomes. The market is propelled by the rising prevalence of chronic diseases, increasing organ transplant procedures, and growing investment in molecular diagnostic technologies. Furthermore, ongoing innovations in assay technologies and expansion of laboratory infrastructure globally are catalyzing market growth.

The growing burden of end-stage organ failure and hematological disorders has accelerated the demand for precise HLA typing solutions. According to global transplant registries, thousands of patients await solid organ or hematopoietic stem cell transplantation annually, highlighting the critical need for high-throughput and reliable HLA testing. Moreover, the adoption of advanced molecular assay techniques, including next-generation sequencing and PCR-based methods, is enhancing the speed and accuracy of HLA typing. Nonetheless, high costs associated with advanced equipment and regulatory complexities could pose challenges to market penetration during the forecast period 2025-2035.

The detailed segments and sub-segments included in the report are:

By Products and Services:
• Reagents and Consumables
• Instruments
• Software and Services

By Technology:
• Molecular Assay Technologies
• Non-Molecular Assay Technologies

By Transplant Type:
• Solid Organ Transplant
• Hematopoietic Stem Cell Transplant

By Application:
• Diagnostic Applications
• Research Applications

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• RoE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Solid Organ Transplant Segment Expected to Dominate the Market

The solid organ transplant segment is anticipated to dominate the HLA typing market due to the high volume of kidney, liver, and heart transplant procedures worldwide. The increasing prevalence of end-stage organ failure and growing transplant programs in developed and emerging economies drive this dominance. Hematopoietic stem cell transplants are also witnessing rapid adoption due to advancements in transplantation techniques and rising incidence of blood-related disorders, making it a significant growth opportunity.

Reagents and Consumables Lead in Revenue Contribution

Among products and services, reagents and consumables currently generate the largest revenue share, as they are essential for daily laboratory operations and frequent HLA testing requirements. Instruments and software services contribute substantially to revenue, with molecular assay technologies witnessing the fastest growth due to high sensitivity, precision, and rising adoption in clinical and research laboratories. This dual trend illustrates a market landscape where consumables provide steady revenue while innovative instruments drive accelerated expansion.

North America led the HLA typing transplant market in 2025, underpinned by well-established healthcare infrastructure, advanced laboratory facilities, and high organ transplant volumes. Europe follows closely, benefiting from strong regulatory frameworks and growing government initiatives supporting transplant programs. Asia Pacific is projected to exhibit the fastest growth over the forecast period, driven by increasing healthcare expenditure, rising awareness regarding transplantation compatibility, and expanding diagnostic infrastructure. Latin America and the Middle East & Africa are gradually gaining traction, fueled by growing transplant centers and rising adoption of advanced HLA typing technologies.

Major market players included in this report are:
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Qiagen N.V.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Agilent Technologies, Inc.
• PerkinElmer, Inc.
• Abbott Laboratories
• Hologic, Inc.
• Olerup SSP AB
• BioMérieux SA
• GenDx
• CareDx, Inc.
• Lonza Group AG
• Immucor, Inc.

Global HLA Typing Transplant Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained above.

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of the competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more